- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0174797

About Saffron Therapeutics Private Limited
Data last updated:
Saffron Therapeutics Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2014PTC080089. Its GSTIN is 24AAUCS7031C1ZD (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Amit Singh and Hiren Rameshchandra Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.35 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹6.45 Lakh (net margin 1.9%) and EBITDA of ₹24.32 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 1% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
Court records list 15 cases involving the company, including 7 filed by the company and 8 filed against it; 3 cases are pending.
Saffron Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0174797). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saffrontherapeutics.com.
Company details
Recognitions & Rankings of Saffron Therapeutics
Contact details
Saffron Therapeutics Private Limited's registered office is in Ahmedabad, Gujarat. Its website is saffrontherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address7th Floor 702 Times Square Arcade Opp. Rambaug, Nr. Ravija Plaza Thaltej – Shilaj Road, Ahmedabad, Gujarat, India – 380059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Saffron Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saffron Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Saffron Therapeutics Private Limited, buy the company report.
Financials of Saffron Therapeutics Private Limited
FY 2025 filings availableSaffron Therapeutics Private Limited reported revenue of ₹3.35 Cr (up 82% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 82% growth in the latest year. EBITDA fell 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saffron Therapeutics Private Limited, buy the company report.
Board of directors of Saffron Therapeutics Private Limited
Saffron Therapeutics has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Singh Also directs: Saffron Formulations Private Limited | Director | 10 Jul 2014 | 12 Years 3 Months | Current |
| Hiren Rameshchandra Patel Also directs: Saffron Formulations Private Limited | Director | 25 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Saffron Therapeutics Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Qualchem Healthcare Private Limited | ₹3.36 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Azcad Pharmaceuticals Private Limited | ₹3.36 Cr (FY 2025) | 10.0% | Chennai, Tamil Nadu, India | |||
| Bricent Healthcare Private Limited | ₹3.35 Cr (FY 2025) | 24.0% | Hyderabad, Telangana, India | |||
| Saffron Therapeutics Private Limitedthis company | ₹3.35 Cr (FY 2025) | ₹6.45 Lakh | 1.9% | 82.0% | 1 | Ahmedabad, Gujarat, India |
| Jeen Lifesciences Private Limited | ₹3.35 Cr (FY 2025) | 10.0% | Kolkata, West Bengal, India | |||
| A.S.B.Agencies Private Limited | ₹3.34 Cr (FY 2021) | -23.0% | Tambaram, Madras-45, Tamil Nadu, India | |||
| Cinerea Biotech Private Limited | ₹3.34 Cr (FY 2025) | 2.0% | Chandigarh, India |
To see the full peer comparison of Saffron Therapeutics Private Limited, buy the company report.
Auditor
Saffron Therapeutics Private Limited is audited by APAJI AMIN AND CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APAJI AMIN AND CO. LLP | FY 2023 | 100513W/W100062 |
Shareholding
The shareholding of Saffron Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Saffron Therapeutics Private Limited, buy the company report.
Legal cases
Saffron Therapeutics Private Limited has 15 court cases on record: 7 filed by Saffron Therapeutics, 8 filed against it. 3 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 4 | 3 |
| High courts | 5 | 4 | 0 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Alkem Laboratories Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against The Proprietor, M/S S. R. Distributor | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ahmedabad, Gujarat | Civil suit | Filed by the company against an individual | Pending |
| NCLT, Ahmedabad | Interim or miscellaneous application | Filed by the company | Disposed |
To see the full case history of Saffron Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saffron Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Saffron Therapeutics Private Limited has a workforce of 1 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
GST
Saffron Therapeutics has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAUCS7031C1ZD | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saffron Therapeutics Private Limited, buy the company report.
Recent activity
Saffron Therapeutics Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Omkarchandra Rikhabdas Maloo ceased to be Irp/Rp/Liquidator on 31 Dec 2024.
Frequently asked questions
Saffron Therapeutics is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 July 2014 (12+ years old) and is registered under CIN U24233GJ2014PTC080089.
Saffron Therapeutics has 2 current directors:
- Amit Singh - Director
- Hiren Rameshchandra Patel - Director
The latest financial statements of Saffron Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Saffron Therapeutics is 24AAUCS7031C1ZD, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Saffron Therapeutics is U24233GJ2014PTC080089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saffron Therapeutics has 15 court cases on record: 7 filed by the company and 8 filed against it. 3 are pending. Most are in the district courts.
Saffron Therapeutics was incorporated on 10 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Saffron Therapeutics by revenue are Qualchem Healthcare Private Limited, Azcad Pharmaceuticals Private Limited, Bricent Healthcare Private Limited, Jeen Lifesciences Private Limited, A.S.B.Agencies Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Omkarchandra Rikhabdas Maloo ceased to be Irp/Rp/Liquidator on 31 Dec 2024. Anilkumar Umraosingh Negi ceased to be Director on 06 Nov 2024. Ram Appasaheb Magar ceased to be Additional Director on 29 Sep 2017. Saffron Therapeutics has 7 board changes on record in total.
Yes, Saffron Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0174797).
Saffron Therapeutics can be reached through the website saffrontherapeutics.com. Its registered office is in Ahmedabad, Gujarat, India.

